Azithromycin in early infancy and pyloric stenosis

Pediatrics

Volumn 135, Issue 3, 2015, Pages 483-488

  Eberly, Matthew D ^a   Eide, Matilda B ^a   Thompson, Jennifer L ^a   Nylund, Cade M ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFALEXIN; ERYTHROMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; COHORT ANALYSIS; EXPOSURE; FEMALE; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; INFANCY; INFANT; INFANTILE HYPERTROPHIC PYLORIC STENOSIS; INFANTILE HYPERTROPHIC PYLORUS STENOSIS; INFATILE HYPERTROPHIC PYLORIC STENOSIS; MALE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; PYLOROMYOTOMY; RETROSPECTIVE STUDY; RISK FACTOR; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; FOLLOW UP; INCIDENCE; MULTICENTER STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; PROCEDURES; PROGNOSIS; PYLORIC STENOSIS, HYPERTROPHIC; RISK; RISK ASSESSMENT; UNITED STATES; WHOOPING COUGH;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; ODDS RATIO; OUTPATIENTS; PROGNOSIS; PYLORIC STENOSIS, HYPERTROPHIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; WHOOPING COUGH;

EID: 84924285346     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2026     Document Type: Article

References (18)

1. Jedd MB, Melton LJ III, Griffin MR, et al. Factors associated with infantile hypertrophic pyloric stenosis. Am J Dis Child. 1988;142(3):334-337
2. Applegate MS, Druschel CM. The epidemiology of infantile hypertrophic pyloric stenosis in New York State, 1983 to 1990. Arch Pediatr Adolesc Med. 1995; 149(10):1123-1129
3. Krogh C, Fischer TK, Skotte L, et al. Familial aggregation and heritability of pyloric stenosis. JAMA. 2010;303(23): 2393-2399
4. SanFilippo A. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: a report of five cases. J Pediatr Surg. 1976;11(2): 177-180
5. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med. 1986;69(11): 669-670, 682
6. Centers for Disease Control and Prevention (CDC). Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin - Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep. 1999;48(49):1117-1120
7. Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. Lancet. 1999;354(9196): 2101-2105
8. Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr. 2001;139(3): 380-384
9. Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med. 2002;156(7): 647-650
10. Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J. 2007; 26(2):186-188
11. Schechter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epidemiol. 1997;11(4):407-427
12. American Academy of Pediatrics. Pertussis. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012:555
13. Friedman DS, Curtis CR, Schauer SL, et al. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol. 2004; 25(11):967-973
14. Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol. 1989;257(3 pt 1):G470-G474
15. Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev. 2008;16(3):CD001815
16. Broad J, Sanger GJ. The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. Br J Pharmacol. 2013;168(8):1859-1867
17. Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci. 2010;55(3):675-683
18. Chini P, Toskes PP, Waseem S, Hou W, McDonald R, Moshiree B. Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. Scand J Gastroenterol. 2012; 47(4):422-427